Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 15 Issue 12, November 1997

Editorial

Top of page ⤴

Commentary

Top of page ⤴

Correspondence

Top of page ⤴

Business and Regulatory News

Top of page ⤴

Research News

Top of page ⤴

This Month in Biotechnology

Top of page ⤴

Analysis

Top of page ⤴

Feature

  • Pharmacogenomics will help explain why drugs work better in some patients than in others. These tools should be used as early in the drug development process as possible.

    • Andrew Marshall
    Feature
Top of page ⤴

Research Review

Top of page ⤴

Research Article

Top of page ⤴

Patents

Top of page ⤴

WWW Guide

Top of page ⤴

Profile

  • The new head of Glaxo Wellcome's genetic directorate brings a strong vision of the role of disease genetics in molecular medicine.

    • Vicki Brower
    Profile
Top of page ⤴

People

Top of page ⤴

New Products

Top of page ⤴

Industry Trends

  • Some companies are taking an active interest in this promising technology.

    • Aris Persidis
    Industry Trends
Top of page ⤴

Search

Quick links